Sunday, January 28, 2024

Oil drillers defy freezing temperatures

U.S. oil drillers just hit 13 million barrels per day amid freezing temperatures.

The unexpected outcome of their unwavering determination is further proof that despite the Biden Administration's claims about the clean energy transition…

Oil remains the more lucrative energy play for in-the-know investors today.

Full story here + one way to target big oil profits in your next trade.





Something Stinks In This $516 Billion Industry


Usually, the FDA approves a drug, and the drugmaker's share price soars.

But the story has changed, and this trend holds the clue to your next big trade.

Just look at Biogen and Eisa. Co. Their shares fell by over 3% after the FDA's full approval of LEQEMBI, their new Alzheimer's disease treatment.

And something similar happened to BioMarin Pharmaceutical and Sarepta Therapeutics.

Their shares fell by 6% and 16%, respectively, after the FDA approved their gene therapies for two big diseases: hemophilia A and Duchenne muscular dystrophy.

I could share more examples but the question here is….

If big investors like Warren Buffett are exiting their positions in biotech stocks, (due to the gloomy outlook) where are they putting that cash for hefty returns?

And more importantly, how do you structure your trades to share in the gains?

That's what a 20-year trading veteran will show you today (join him here).

To big profits and beyond,

 

team1@hawkeyetraders.com
bigenergyprofits.com


Call us: (888) 233-8598

DISCLAIMER: * Futures, stocks, and spot currency trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures, stocks, and forex markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures, stocks or forex. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. Past performance of indicators or methodology are not necessarily indicative of future results.

CFTC Regulation 4.41 These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown.

We'll always treat your personal information with the utmost care and will never sell it to third parties. You can find out more about what data we hold about you, why we need it, and how we keep that information safe in our Privacy Policy.

No comments:

Post a Comment

Your Weekly Recommended Reads

Powered by AI, personalised for you Catch up on key news and analysis from the week gone by with The Business of Fashion's My...